Identifying Opioid Overdose Predictors using EHRs

Information

  • Research Project
  • 10131165
  • ApplicationId
    10131165
  • Core Project Number
    R01DA045816
  • Full Project Number
    5R01DA045816-04
  • Serial Number
    045816
  • FOA Number
    PAR-16-234
  • Sub Project Id
  • Project Start Date
    7/15/2018 - 7 years ago
  • Project End Date
    3/31/2023 - 2 years ago
  • Program Officer Name
    SU, SHELLEY
  • Budget Start Date
    4/1/2021 - 4 years ago
  • Budget End Date
    3/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    3/16/2021 - 4 years ago

Identifying Opioid Overdose Predictors using EHRs

Identifying Opioid Overdose Predictors using EHRs Pain and effective pain management are among the most critical health issues facing Americans. In 2011, the Institute of Medicine reported that as many as one-third of all Americans experience persistent pain at an annual cost of as much as $635 billion in medical treatment and lost productivity. Prescription opioids are increasingly used to treat acute and chronic pain. To date, epidemiologic research defining opioid-related adverse drug event (ADE) risk factors has relied on broad, static categorizations of risk derived from diagnostic codes. Though important foundational work, these studies have three important limitations: (1) they focus on only the most catastrophic ADE (overdose) and thus miss the opportunity to identify less severe, prodromal ADEs (e.g. fatigue, dizziness, sleepiness, over-sedation) that may precede and predict overdose; (2) they do not reliably capture aberrant drug-related behaviors (ADRBs)?risky patterns of use that may affect overdose risk; and (3) they rely on clinician- coded diagnoses in structured data, which have notoriously weak sensitivity and specificity, and neglect rich opioid-related information from unstructured clinical narratives. To address this gap, we propose a stepwise approach that leverages the power of electronic health records and new computational methdologies to explore associations among prodromal adverse events, ADRBs, and overdose. This approach is critical to the development of next-generation opioid overdose prevention tools.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    5
  • Direct Cost Amount
    451251
  • Indirect Cost Amount
    121261
  • Total Cost
    572512
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIDA:572512\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF MASSACHUSETTS LOWELL
  • Organization Department
    BIOSTATISTICS & OTHER MATH SCI
  • Organization DUNS
    956072490
  • Organization City
    LOWELL
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    018543643
  • Organization District
    UNITED STATES